XML 16 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONDENSED CONSOLIDATED BALANCE SHEET - USD ($)
$ in Millions
Mar. 31, 2018
Dec. 31, 2017
Current Assets    
Cash and cash equivalents $ 4,483 $ 6,092
Short-term investments 2,863 2,406
Accounts receivable (net of allowance for doubtful accounts of $205 in 2018 and $210 in 2017) 7,245 6,873
Inventories (excludes inventories of $1,136 in 2018 and $1,187 in 2017 classified in Other assets - see Note 7) 5,382 5,096
Other current assets 4,112 4,299
Total current assets 24,085 24,766
Investments 11,033 12,125
Property, Plant and Equipment, at cost, net of accumulated depreciation of $16,483 in 2018 and $16,602 in 2017 12,561 12,439
Goodwill 18,304 18,284
Other Intangibles, Net 13,500 14,183
Other Assets 6,558 6,075
Total Assets 86,041 87,872
Current Liabilities    
Loans payable and current portion of long-term debt 2,055 3,057
Trade accounts payable 3,162 3,102
Accrued and other current liabilities 9,709 10,427
Income taxes payable 717 708
Dividends payable 1,317 1,320
Total current liabilities 16,960 18,614
Long-Term Debt 21,501 21,353
Deferred Income Taxes 2,206 2,219
Other Noncurrent Liabilities 11,473 11,117
Merck & Co., Inc. Stockholders’ Equity    
Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2018 and 2017 1,788 1,788
Other paid-in capital 39,874 39,902
Retained earnings 41,107 41,350
Accumulated other comprehensive loss (5,060) (4,910)
Stockholders' equity before deduction for treasury stock 77,709 78,130
Less treasury stock, at cost: 884,622,139 shares in 2018 and 880,491,914 shares in 2017 44,041 43,794
Total Merck & Co., Inc. stockholders’ equity 33,668 34,336
Noncontrolling Interests 233 233
Total equity 33,901 34,569
Liabilities and Equity $ 86,041 $ 87,872